Status:
COMPLETED
Safety of Continuous Potassium Chloride Infusion in Critical Care
Lead Sponsor:
The Queen Elizabeth Hospital
Conditions:
Hypokalemia
Arrhythmias, Cardiac
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients in critical care often require supplemental potassium chloride if levels in their blood are below acceptable level. Common practice is to administer a single dose of potassium chloride under ...
Detailed Description
The use of potassium supplementation is commonplace in the critical care environment. Patients often have abnormal serum potassium levels due to active disease processes. Conditions such as acute rena...
Eligibility Criteria
Inclusion
- Any inpatient on the investigating unit with a serum potassium level of less than 3.8mmol/L
- arterial line for blood sampling and central venous access for infusion administration in situ
- continuous 12-lead ECG monitoring
Exclusion
- Patients with a serum potassium ≥ 3.8mmol/L
- Renal dysfunction with serum creatinine 50% greater than the upper end of the normal reference range (i.e.: \> 180micromol/L) or urine output less than 0.5ml/kg/hr for 6 consecutive hours, or the requirement for dialysis
- Burns
- Hypomagnesaemia (≤ 0.7mmol/L), however patients may be enrolled after the hypomagnesaemia is corrected
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00718068
Start Date
October 1 2008
End Date
October 1 2009
Last Update
July 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Queen Elizabeth Hospital
Woodville South, South Australia, Australia, 5011